United Therapeutics

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. In these segments, United Therapeutics is actively developing four technology platforms: Prostacyclin Analogs, Immunotherapeutic Monoclonal Antibodies, Glycobiology, and Telemedicine. At United Therapeutics, we find tremendous inspiration for our work and view our products as being new beginnings for patients and doctors, with quality of life as our utmost therapeutic goal. The theme of United Therapeutics is "Medicines for Life" because all of our therapeutics address life-threatening illnesses.

Contact Details: 1110 Spring Street Silver Spring MD 20910 United States of America Tel: 301 608 9292 Fax: 301.608.9291 Email: webmaster@unither.com WWW: www.unither.com/

Loading...

Recent Publications by United Therapeutics:
Dose proportionality of treprostinil sodium administered by continuous subcutaneous and intravenous infusion. This study assessed the relationship between dose and plasma concentration...	19th April, 2008	Clinical Affairs, United Therapeutics Corporation, One Park Drive, 4th	J Clin Pharmacol. 2008 Jan;48(1):19-25. DOI Direct Link
Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms. This study assessed the relationship between dose and plasma concentration...	9th December, 2006	United Therapeutics Corporation, Research Triangle Park, North Carolina	Pharmacotherapy. 2006 Aug;26(8):1203; discussion 1203-4. DOI Direct Link
Pharmacokinetics and steady-state bioequivalence of treprostinil sodium (Remodulin) administered by the intravenous and subcutaneous route to normal volunteers. Treprostinil sodium is a chemically stable analogue of prostacyclin...	29th April, 2005	United Therapeutics Corporation, Research Triangle Park, North Carolina	J Cardiovasc Pharmacol. 2004 Aug;44(2):209-14.
Pulmonary hypertension. Pulmonary hypertension, in its simplest sense, is elevation of the...	26th February, 2005		Curr Probl Cardiol. 2004 Oct;29(10):575-634. DOI Direct Link
Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion. The objective of this study was to assess the pharmacokinetics and safety...	17th December, 2004	United Therapeutics Corporation, One Park Drive, P.O. Box 14186, Research	J Clin Pharmacol. 2004 May;44(5):503-9. DOI Direct Link
→View more United Therapeutics research publications.

BioNews Results for United Therapeutics:
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc	SmartBrief:  Oct 5 2008 5:39AM Matching: united therapeutics
BIOTECHNICA 2008 to Feature Cornucopia of Cutting-Edge Topics	Pharma Live:  Oct 5 2008 7:50AM Matching: united therapeutics
Stem Cell Therapeutics Corp. Announces Final Payment to Transition Therapeutics Inc. to Complete the Acquisiti	NewsBlaze:  Oct 4 2008 2:45AM Matching: united therapeutics
AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)	KRON4:  Oct 4 2008 6:18AM Matching: united therapeutics
Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subs	KRON4:  Oct 4 2008 6:16AM Matching: united therapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more United Therapeutics news.

United Therapeutics Patents:
US Patent No.	Title
7417070	Compounds and methods for delivery of prostacyclin analogs
6441245	Process for stereoselective synthesis of prostacyclin derivatives
6521212	Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
6528688	Prostacyclin derivatives
6700025	Process for stereoselective synthesis of prostacyclin derivatives
→View more United Therapeutics patents.

United Therapeutics (UTHR) Financial information Links from Barchart
UTHR Quote from from Barchart.com
UTHR Chart from from Barchart.com
UTHR Profile from from Barchart.com
UTHR Opinion from from Barchart.com
→View more United Therapeutics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 252 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: United Therapeutics uk manager | united therapeutics one park drive | united therapeutics company relationships | united therapeutics | .

Search for more companies in Silver Spring

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for United Therapeutics